EU Stem-Cell Patent Debate Nearly Over After 20 Years
EU Stem-Cell Patent Debate Nearly Over After 20 Years
Leslie Chong is a JD candidate at Osgoode Hall Law School. The European Court of Justice’s (ECJ) has ruled against the patentability of human embryonic stem (hES) cell lines and, in doing so, it has articulated the standard for acceptable practice in the use and commercial exploitation of stem-cell research in the EU.